Browse
Submit Data
Databases
API
Help

Dataset Information

12 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

4,5,6,7-Tetra-chloro-N-(2,3,4-trifluoro-phen-yl)phthalimide.

ABSTRACT: The asymmetric unit of the title compound, C(14)H(2)Cl(4)F(3)NO(2), contains two independent mol-ecules. In each mol-ecule, the phthalimide ring system is nearly planar [maximum atomic deviation = 0.031?(2) or 0.038?(2)?Å] and oriented with respect to the benzene ring at 65.04?(7) or 71.76?(10)°. Weak inter-molecular C-H?O and C-H?F hydrogen bonding is present in the crystal structure.

SUBMITTER: Zhang YJ

PROVIDER: S-EPMC3151790 | biostudies-literature | 2011 Jul

REPOSITORIES: biostudies-literature

ACCESS DATA

Json Xml

Publications

4,5,6,7-Tetra-chloro-N-(2,3,4-trifluoro-phen-yl)phthalimide.

Zhang Yin-Jun YJ Luo Chen-Tao CT Wang Yu-Guang YG Wang Zhao Z

Acta crystallographica. Section E, Structure reports online 20110611 Pt 7

The asymmetric unit of the title compound, C(14)H(2)Cl(4)F(3)NO(2), contains two independent mol-ecules. In each mol-ecule, the phthalimide ring system is nearly planar [maximum atomic deviation = 0.031 (2) or 0.038 (2) Å] and oriented with respect to the benzene ring at 65.04 (7) or 71.76 (10)°. Weak inter-molecular C-H⋯O and C-H⋯F hydrogen bonding is present in the crystal structure. ...[more]

PMID: 21837012

Similar Datasets

N-(2,3,4-Trifluoro-phen-yl)phthalimide.

Project description:In the title compound, C(14)H(6)F(3)NO(2), the benzene ring and the phthalimide ring system make a dihedral angle of 60.12?(7)°. Weak inter-molecular C-H?O and C-H?F hydrogen bonds are present in the crystal structure.

| S-EPMC3006749 | biostudies-literature

4,5,6,7-Tetra-chloro-N-(2-fluoro-phen-yl)phthalimide.

Project description:In the title compound, C(14)H(4)Cl(4)FNO(2), the benzene ring and the phthalimide plane are nearly planar, the maximum deviations being 0.005?(2) and 0.010?(2)?Å, respectively, but the mol-ecule as a whole is not planar: the dihedral angle between the two planar ring systems is 68.06?(10)°. A short Cl?O contact of 2.914?(2)?Å exists in the crystal structure.

| S-EPMC3008021 | biostudies-other

4,5,6,7-Tetra-chloro-2-(2,2,2-trifluoro-eth-yl)isoindoline-1,3-dione.

Project description:In the title compound, C(10)H(2)Cl(4)F(3)NO(2), the isoindoline ring system is almostplanar, the maximum atomic deviation being 0.064?(2)?Å. The C-C bond of the ethyl-ene group is twisted with respect to the isoindoline plane by a dihedral angle of 59.58?(12)°. In the crystal, weak inter-molecular C-H?F hydrogen bonding links the mol-ecules into supra-molecular chains running along the a axis. A short inter-molecular Cl?O contact of 2.950?(3)?Å is also observed.

| S-EPMC3006784 | biostudies-literature

4,5,6,7-Tetra-chloro-2-(4-fluoro-phen-yl)isoindoline-1,3-dione.

Project description:The title compound, C(14)H(4)Cl(4)FNO(2), has crystallographic twofold symmetry with the N and F atoms and two C atoms of the benzene ring located on a twofold rotation axis. The isoindole-dione ring system is almost planar [maximum atomic deviation = 0.036 (3) Å], and is twisted with respect to the florobenzene ring, making a dihedral angle of 58.56 (16)°. Weak inter-molecular C-H⋯Cl hydrogen bonding is present in the crystal structure.

| S-EPMC3006924 | biostudies-literature

N-(2,3,4-Trifluoro-phen-yl)pyrrolidine-1-carboxamide.

Project description:In the title compound, C(11)H(11)F(3)N(2)O, a urea derivative, the best plane through the pyrrole ring makes a dihedral angle of 9.69?(13)° with the benzene ring. The amino H atom is shielded, so that it is not involved in any hydrogen-bonding inter-actions.

| S-EPMC3254353 | biostudies-literature

N-(2,3,4-Trifluoro-phen-yl)morpholine-4-carboxamide.

Project description:In title mol-ecule, C(11)H(11)F(3)N(2)O(2), the central -N-C(=O)-N- unit is essentially planar [maximum deviation = 0.013?(2)?Å] and forms a dihedral angle of 57.33?(9)° with the benzene ring. The morpholine ring is in a chair conformation. In the crystal, mol-ecules are linked into chains along [001] by N-H?O hydrogen bonds.

| S-EPMC3254354 | biostudies-literature

4-{(4-Chloro-phen-yl)[4-(4-methyl-phen-yl)-1,2,3-selenadiazol-5-yl]meth-yl}-4,5,6,7-tetra-hydro-1,2,3-benzoselenadiazole.

Project description:In the title compound, C(22)H(19)ClN(4)Se(2), the mean plane of the non-fused selenadiazole ring forms dihedral angles of 54.20?(16)° and 70.48?(11)°, respectively, with the essentially planar [maximum deviations of 0.025?(5) and 0.009?(2)?Å, respectively] methyl-phenyl and chloro-phenyl substituents. The tetra-hydro-1,2,3-benzoselenadiazole group is disordered over two sets of sites with a refined occupancy ratio of 0.802?(5):0.198?(5). In the crystal, weak inter-molecular C-H?N inter-actions are observed.

| S-EPMC3120601 | biostudies-literature

1-(4,5,6,7-Tetra-hydro-thieno[3,2-c]pyridin-5-yl)-2-{4-[3-(trifluoro-meth-yl)phen-yl]piperazin-1-yl}ethanone.

Project description:In the title mol-ecule, C(20)H(22)F(3)N(3)OS, the piperazine ring has a chair conformation, and the N-C(=O)-C-N torsion angle is -59.42?(14)°. In the crystal, weak C-H?O and C-H?? inter-actions link the mol-ecules into layers parallel to (101).

| S-EPMC3344441 | biostudies-literature

3-Bromo-propyl 2-(2-chloro-phen-yl)-2-(4,5,6,7-tetra-hydro-thieno[3,2-c]pyridin-5-yl)acetate.

Project description:In the crystal structure of the title compound, C(18)H(19)BrClNO(2)S, weak C-H?O inter-actions help to establish the packing.

| S-EPMC3050151 | biostudies-literature

4,5,6,7-Tetra-bromo-1,1,3-trimethyl-3-(2,3,4,5-tetra-bromo-phen-yl)indane.

Project description:The title compound (OctaInd), C(18)H(12)Br(8), is a commercial brominated flame retardant (BFR). In the mol-ecule, the five-membered ring has a slight envelope conformation, with a deviation of 0.317?(9)?Å for the flap C atom from four essentially planar C atoms. The dihedral angle between the two benzene rings is 74.00?(16)?Å.

| S-EPMC2960393 | biostudies-literature

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data